1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > 2016 Emerging Opportunities in the CA Tumor Marker Testing Market

2016 Emerging Opportunities in the CA Tumor Marker Testing Market

  • October 2015
  • -
  • Venture Planning Group
  • -
  • 278 pages

This report contains 278 pages, 40 tables and presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 278 pages and 40 tablesThis report contains 278 pages, 40 tables and presents a detailed analysis of the CA 15-3/27.29, CA 19-9, and CA 125 testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume and sales forecasts by country and market segment; as well as sales and market shares for major suppliers.

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

The report also examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies, immunoassays, IT, chromosome analysis, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 278 pages and 40 tables

Table Of Contents

2016 Emerging Opportunities in the CA Tumor Marker Testing Market



List of Tables
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
France
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
France
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
France
CA 125 Test Volume and Diagnostics Sales
by Market Segment
France
CA 15-3/27.29 Testing Market by Major Supplier
France
CA 19-9 Testing Market by Major Supplier
France
CA 125 Testing Market by Major Supplier
Germany
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Germany
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment


Germany
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Germany
CA 15-3/27.29 Testing Market by Major Supplier
Germany
CA 19-9 Testing Market by Major Supplier
Germany
CA 125 Testing Market by Major Supplier
Italy
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Italy
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Italy
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Japan
CA 15-3/27.29 Testing Market by Major Supplier


Japan
CA 19-9 Testing Market by Major Supplier
Japan
CA 125 Testing Market by Major Supplier
Spain
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 125 Test Volume and Diagnostics Sales
by Market Segment
Spain
CA 15-3/27.29 Testing Market by Major Supplier
Spain
CA 19-9 Testing Market by Major Supplier
Spain
CA 125 Testing Market by Major Supplier
U.K.
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
U.K.
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
U.K.
CA 125 Test Volume and Diagnostics Sales
by Market Segment

U.S.A.
CA 15-3/27.29 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 19-9 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 125 Test Volume and Diagnostics Sales
by Market Segment
U.S.A.
CA 15-3/27.29 Testing Market by Major Supplier
U.S.A.
CA 19-9 Testing Market by Major Supplier
U.S.A.
CA 125 Testing Market by Major Supplier

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.